Patton Fund Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,527
Closed -$284K 206
2026
Q1
$284K Buy
+4,527
New +$315K 0.05% 194
2025
Q4
Sell
-3,073
Closed -$207K 477
2025
Q3
$207K Hold
3,073
0.04% 435
2025
Q2
$268K Buy
+3,073
New +$241K 0.06% 124
2023
Q4
Sell
-16,499
Closed -$1.54M 79
2023
Q3
$1.54M Sell
16,499
-10,955
-40% -$1.23M 0.42% 53
2023
Q2
$3.53M Buy
+27,454
New +$3.32M 1.03% 20
2020
Q4
Sell
-17,380
Closed -$1.79M 82
2020
Q3
$1.79M Buy
+17,380
New +$1.82M 0.97% 28

Other funds holding DXCM

Patton Fund Management's DXCM Position: Q2 2026 in Review

Patton Fund Management sold out of DexCom (DXCM) in Q2 2026, closing a stake of 4,527 shares — an estimated $284K sold.

Patton Fund Management first reported a position in DXCM in Q3 2020 and held it in 6 quarters. The position peaked at $3.53M in Q2 2023. 279 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Patton Fund Management reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Patton Fund Management sold 4,527 DexCom shares in Q2 2026, an estimated $284K.
  • Patton Fund Management first reported a position in DexCom in Q3 2020 and held it in 6 quarters.
  • Patton Fund Management's DexCom position peaked at $3.53M in Q2 2023.
  • 279 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Patton Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.